During the past decade, Mulago Hospital Sickle Cell Clinic conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Mulago Hospital Sickle Cell Clinic" #1 collaborator was "Children's Hospital Medical Center, Cincinnati" with 2 trials as a collaborator, "Doris Duke Charitable Foundation" with 2 trials as a collaborator, "Makerere University" with 2 trials as a collaborator and "Mulago Hospital, Uganda" with 2 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Mulago Hospital Sickle Cell Clinic" are "Malaria" (2 trials), "Sickle Cell Anemia" (2 trials) and "Sickle Cell Disease" (2 trials). Many other conditions were trialed in "Mulago Hospital Sickle Cell Clinic" in a lesser frequency.

Most popular intervention types in "Mulago Hospital Sickle Cell Clinic" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Hydroxyurea" (2 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Mulago Hospital Sickle Cell Clinic" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Mulago Hospital Sickle Cell Clinic". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Mulago Hospital Sickle Cell Clinic, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Mulago Hospital Sickle Cell Clinic, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".